Abstract
ENDOGENOUS neuromodulatory molecules are commonly coupled to specific metabolic enzymes to ensure rapid signal inactivation. Thus, acetylcholine is hydrolysed by acetylcholine esterase1 and tryptamine neurotransmitters like serotonin are degraded by monoamine oxidases2. Previously, we reported the structure and sleep-inducing properties of cis-9-octadecenamide, a lipid isolated from the cerebrospinal fluid of sleep-deprived cats3, cis-9-Octadecenamide, or oleamide, has since been shown to affect serotonergic systems4 and block gap-junction communication in glial cells (our unpublished results). We also identified a membrane-bound enzyme activity that hydrolyses oleamide to its inactive acid, oleic acid3. We now report the mechanism-based isolation, cloning and expression of this enzyme activity, originally named oleamide hydrolase5, from rat liver plasma mem-branes. We also show that oleamide hydrolase converts anandamide, a fatty-acid amide identified as the endogenous ligand for the cannabinoid receptor6, to arachidonic acid, indi-cating that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling molecules, the fatty-acid amides6–8. Therefore we will hereafter refer to oleamide hydrolase as fatty-acid amide hydrolase, in recognition of the plurality of fatty-acid amides that the enzyme can accept as substrates.
Similar content being viewed by others
References
MacPhee-Quigley, K., Taylor, P. & Taylor, S. J. Biol. Chem. 260, 12185–12189 (1985).
Singer, T. P. & Ramsay, R. R. FASEB J. 9, 605–610 (1995).
Cravatt, B. F. et al. Science 268, 1506–1509 (1995).
Huidobro-Toro, J. P. & Harris, R. A. Proc. Natl Acad. Sci. USA 93, 8078–8082 (1996).
Patterson, J. E. et al. J. Am. Chem. Soc. 118, 5938–5945 (1996).
Devane, W. A. et al. Science 258, 1946–1949 (1992).
Wakamatsu, K. et al. Biochem. Biophys. Res. Commun. 168, 423–429 (1990).
Facci, L. et al. Proc. Natl Acad. Sci. USA 92, 3376–3380 (1995).
Klee, H. et al. Proc. Natl Acad. Sci. USA 81, 1728–1732 (1984).
Yamada, T., Palm, C. J., Brooks, B. & Kosuge, T. Proc. Natl Acad. Sci. USA 82, 6522–6526 (1985).
Corrick, C. M., Twomey, A. P. & Hynes, M. J. Gene 53, 63–71 (1987).
Chang, T.-H. & Abelson, J. Nucleic Acids Res. 18, 7180 (1990).
Wilson, R. et al. Nature 368, 32–38 (1994).
Ettinger, R. A. & DeLuca, H. F. Arch. Biochem. Biophys. 316, 14–19 (1995).
Mayaux, J.-F. et al. J. Bacteriol. 172, 6764–6773 (1990).
Feng, S., Chen, J. K., Yu, H., Simon, J. A. & Schreiber, S. L. Science 266, 1241–1246 (1994).
Pawson, T. Nature 373, 573–580 (1995).
Rotin, D. et al. EMBO J. 13, 4440–4450 (1994).
Maurelli, S. et al. FEBS Lett. 377, 82–86 (1995).
Ueda, N., Kurahashi, Y., Yamamoto, S. & Tokunaga, T. J. Biol. Chem. 270, 23823–23827 (1995).
Desarnaud, F., Cadas, H. & Piomelli, D. J. Biol. Chem. 270, 6030–6035 (1995).
Deutsch, D. G. & Chin, S. A. Biochem. Pharmacol. 46, 791–796 (1993).
Cravatt, B. F., Lerner, R. A. & Boger, D. L. J. Am. Chem. Soc. 118, 580–590 (1996).
Boivin, J., El Kaim, L. & Zard, S. Z. Tetrahedron Lett. 33, 1285–1288 (1992).
Falk, M. M., Kumar, N. M. & Gilula, N. B. J. Cell Biol. 127, 343–355 (1994).
Fernandez, J., Andrews, L. & Mische, S. M. Anal. Biochem. 218, 112–117 (1994).
Abdel-Aal, Y. A. I. & Hammock, B. D. Science 233, 1073–1076 (1986).
Imperiali, B. & Abeles, R. H. Biochemistry 25, 3760–3767 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cravatt, B., Giang, D., Mayfield, S. et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83–87 (1996). https://doi.org/10.1038/384083a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/384083a0
- Springer Nature Limited
This article is cited by
-
Association between the FAAH C385A variant (rs324420) and obesity-related traits: a systematic review
International Journal of Obesity (2024)
-
Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use
Neuropsychopharmacology (2024)
-
The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies
Current HIV/AIDS Reports (2024)
-
Endocannabinergic modulation of central serotonergic activity in healthy human volunteers
Annals of General Psychiatry (2023)
-
Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors
Neurotoxicity Research (2023)